The $45.8m investment will increase active pharmaceutical ingredient (API) production capacity at Delmar’s LaSalle Borough facility in the Quebec region of Canada.
The firm will purchase specialised equipment for its finishing room to complete the production cycle of active pharmaceutical ingredients in-house, and expand the plant to make room for the indoor storage of production materials.
The Government of Quebec is supporting the expansion through a repayable $10m grant and a $1.5m contribution through its Canada Economic Development for Quebec Regions (CED) programme.
25 jobs are expected to be created.
Delmar – part of Italian firm Holding F.I.S. S.p.A which owns F.I.S. (Fabbrica Italiana Sintetici) and P.H.F. (Partner of Holding F.I.S. S.p.A) – did not reply to this publication when contacted.